Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from dorsaVi Limited ( (AU:DVL) ) is now available.
dorsaVi Limited has applied to the ASX for quotation of 2,342,009 new fully paid ordinary shares under the code DVL, with the securities issued on 23 December 2025. The additional quoted shares, which arise from previously announced transactions, will modestly expand the company’s free float and equity base, potentially enhancing liquidity in its stock and supporting ongoing corporate and capital management initiatives for existing and prospective shareholders.
The most recent analyst rating on (AU:DVL) stock is a Sell with a A$0.04 price target. To see the full list of analyst forecasts on dorsaVi Limited stock, see the AU:DVL Stock Forecast page.
More about dorsaVi Limited
dorsaVi Limited (ASX: DVL) is an Australian-listed company; based on its profile as an ASX issuer, it operates as a publicly traded entity providing products or services within the technology and health analytics space, though this filing focuses solely on its capital market activity rather than its operations or markets.
Average Trading Volume: 4,899,965
Technical Sentiment Signal: Hold
Current Market Cap: A$33.76M
See more insights into DVL stock on TipRanks’ Stock Analysis page.